Boston Scientific
Boston Scientific M00576550 Ultraflex Tracheobronchial Distal Release Stent System 12mm x 30mm Covered 15mm 1/EA
Boston Scientific M00576550 Ultraflex Tracheobronchial Distal Release Stent System 12mm x 30mm Covered 15mm 1/EA
• Model: M00576550
• Expanded Stent Outer Diameter: 12 mm
• Expanded Stent Length: 30 mm
• Cover Length: 15 mm
• Guidewire Compatibility: Compatible with standard 0.035″ Jagwire or pulmonary guidewires
The Boston Scientific M00576550 Ultraflex™ Tracheobronchial Distal Release Stent System is a high-performance airway support solution engineered to restore and maintain patency in compromised tracheobronchial passages. Featuring a 12 mm expanded diameter and 30 mm length with a 15 mm silicone-covered midsection, this stent combines robust airway support with tumor-resistant coverage to help counteract tumor ingrowth and maintain luminal openness. Its knitted nitinol construction delivers consistent radial force while adapting to the natural contours of the airway, supporting improved airflow and patient comfort in cases of malignant or obstructive airway disease.
Designed for precision and procedural control, the Ultraflex stent system utilizes a distal-release delivery catheter with integrated radiopaque markers, enabling clinicians to position the stent accurately under fluoroscopic guidance. Its low-profile, flexible delivery design facilitates smooth navigation through the airway using either flexible or rigid bronchoscopy. Compatible with standard 0.035″ Pulmonary Jagwire™ guidewires, this system provides a reliable pathway for stent deployment even in challenging anatomy or tight strictures.
Intended for sterile, single-use application in interventional pulmonology and thoracic surgery, the Ultraflex Tracheobronchial Stent System (M00576550) helps clinicians address airway obstruction with confidence. Whether deployed for palliative care in malignant strictures or in complex airway management scenarios, this distal-release stent offers a blend of durable construction, controlled placement, and tumor-resistant coverage, enhancing clinical outcomes and procedural efficiency.